Search Results
Search for other papers by John W Cassidy in
Google Scholar
PubMed
Search for other papers by Ankita S Batra in
Google Scholar
PubMed
Search for other papers by Wendy Greenwood in
Google Scholar
PubMed
Search for other papers by Alejandra Bruna in
Google Scholar
PubMed
-derived tumour xenografts (PDTXs) ( Whittle et al. 2015 ), which retain the complex heterogeneity of their originating tumour samples ( DeRose et al. 2011 , Cassidy et al. 2015 , Eirew et al. 2015 ). PDTX models of BC resemble primary tumours across the
Search for other papers by Audrey Ziverec in
Google Scholar
PubMed
Search for other papers by Marie Chanal in
Google Scholar
PubMed
Search for other papers by Perrine Raymond in
Google Scholar
PubMed
Endocrinology Department, “C.I. Parhon” National Institute of Endocrinology, Bucharest, Romania
Search for other papers by Mirela Diana Ilie in
Google Scholar
PubMed
Search for other papers by Dario De Alcubierre in
Google Scholar
PubMed
Search for other papers by Arja Pasternack in
Google Scholar
PubMed
Search for other papers by Olli Ritvos in
Google Scholar
PubMed
Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France
Department of Endocrinology, Reference center for rare pituitary disease (HYPO), Groupement Hospitalier EST, Hospices Civils de Lyon, University of Lyon, Lyon, France
Search for other papers by Gerald Raverot in
Google Scholar
PubMed
Search for other papers by Philippe Bertolino in
Google Scholar
PubMed
of CSF-1 ( Principe et al. 2020 ). These results support the existence of paracrine effects that may be modulated by LβT2 cells in vivo , confirming the need to explore their behaviour and cellular interactions in the context of tumour xenografts
Search for other papers by Silvana Libertini in
Google Scholar
PubMed
Search for other papers by Antonella Abagnale in
Google Scholar
PubMed
Search for other papers by Carmela Passaro in
Google Scholar
PubMed
Search for other papers by Ginevra Botta in
Google Scholar
PubMed
Search for other papers by Sara Barbato in
Google Scholar
PubMed
Search for other papers by Paolo Chieffi in
Google Scholar
PubMed
Search for other papers by Giuseppe Portella in
Google Scholar
PubMed
); a phase I trial of dl922-947 in women with relapsed ovarian cancer is under way ( Baird et al . 2008 ). We have shown that dl922-947 is active against ATC cell lines and tumour xenografts ( Libertini et al . 2008 ). However, data accumulated so
Search for other papers by Haleh Vosgha in
Google Scholar
PubMed
Search for other papers by Armin Ariana in
Google Scholar
PubMed
Genomics Research Centre, Institute of Health and Biomedical Innovation, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia
Search for other papers by Robert Anthony Smith in
Google Scholar
PubMed
Search for other papers by Alfred King-yin Lam in
Google Scholar
PubMed
ability of endothelial cells was imaged using an inverted microscope 4× magnification. Wimasis WimTube (Wimasis GmbH, Munich, Germany) software was used to analyse the number of loops and number of branching points. Tumour xenografts studies in mice
Search for other papers by Lisa K Philp in
Google Scholar
PubMed
Search for other papers by Anja Rockstroh in
Google Scholar
PubMed
Search for other papers by Martin C Sadowski in
Google Scholar
PubMed
Search for other papers by Atefeh Taherian Fard in
Google Scholar
PubMed
Search for other papers by Melanie Lehman in
Google Scholar
PubMed
Search for other papers by Gregor Tevz in
Google Scholar
PubMed
Search for other papers by Michelle S Libério in
Google Scholar
PubMed
Search for other papers by Charles L Bidgood in
Google Scholar
PubMed
Search for other papers by Jennifer H Gunter in
Google Scholar
PubMed
Search for other papers by Stephen McPherson in
Google Scholar
PubMed
Search for other papers by Nenad Bartonicek in
Google Scholar
PubMed
School of Chemistry, University of Melbourne, Melbourne, Victoria, Australia
Search for other papers by John D Wade in
Google Scholar
PubMed
Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary
Search for other papers by Laszlo Otvos in
Google Scholar
PubMed
Search for other papers by Colleen C Nelson in
Google Scholar
PubMed
. Figure 4 (A, B, C, D, E, F, G and H). Efficacious effects of Allo-aca in preventing tumour progression in LNCaP xenograft progression model in castrate nude mice. Impact of Allo-aca on tumour xenograft (A) doubling time (^in cohort growth inhibition
Search for other papers by Lisa K Philp in
Google Scholar
PubMed
Search for other papers by Anja Rockstroh in
Google Scholar
PubMed
Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada
Search for other papers by Melanie Lehman in
Google Scholar
PubMed
Search for other papers by Martin C Sadowski in
Google Scholar
PubMed
Search for other papers by Nenad Bartonicek in
Google Scholar
PubMed
School of Chemistry, University of Melbourne, Melbourne, Victoria, Australia
Search for other papers by John D Wade in
Google Scholar
PubMed
Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary
Search for other papers by Laszlo Otvos Jr in
Google Scholar
PubMed
Search for other papers by Colleen C Nelson in
Google Scholar
PubMed
reproducible nature of the LNCaP line to model PCa progression in vivo (androgen-sensitive, AR-positive, secretes PCa biomarker PSA). ADIPOR agonism suppresses tumour growth in vivo Daily administration of ADP355 slowed LNCaP tumour xenograft
Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano IRCCS, Milan, Italy
Search for other papers by Giovanni Vitale in
Google Scholar
PubMed
Search for other papers by Germano Gaudenzi in
Google Scholar
PubMed
Search for other papers by Luisa Circelli in
Google Scholar
PubMed
Search for other papers by Marco F Manzoni in
Google Scholar
PubMed
Search for other papers by Andrea Bassi in
Google Scholar
PubMed
Search for other papers by Niccolò Fioritti in
Google Scholar
PubMed
Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by on behalf of NIKE Group in
Google Scholar
PubMed
-Viqueira & Hidalgo 2009 ). Another type of xenograft model used in research is the ‘patient-derived tumour xenograft’ (PDX). This model is based on the transfer of primary tumour directly from the patient into an immunodeficient mouse. To accomplish this, patient
Search for other papers by D Alwyn Dart in
Google Scholar
PubMed
Search for other papers by Bradley Spencer-Dene in
Google Scholar
PubMed
Search for other papers by Simon C Gamble in
Google Scholar
PubMed
Search for other papers by Jonathan Waxman in
Google Scholar
PubMed
Search for other papers by Charlotte L Bevan in
Google Scholar
PubMed
on growth of LNCaP/Luc tumour xenografts in nude mice. (A) Relative tumour volume (RTV) of LNCaP/Luc tumours over 36 days. Each point represents the mean± s.e.m . of six to eight observations. Treatment groups assigned on day 20. ** P <0.01, * P <0
Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
processes. The authors highlight the influence of factors such as the extracellular matrix on the biology of cancer cells and introduce the recent evolution of patient-derived tumour xenograft (PDTX) models. The review highlights how PDTX models better
Search for other papers by Tobias Hofving in
Google Scholar
PubMed
Search for other papers by Viktor Sandblom in
Google Scholar
PubMed
Search for other papers by Yvonne Arvidsson in
Google Scholar
PubMed
Search for other papers by Emman Shubbar in
Google Scholar
PubMed
Search for other papers by Gülay Altiparmak in
Google Scholar
PubMed
Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by John Swanpalmer in
Google Scholar
PubMed
Search for other papers by Bilal Almobarak in
Google Scholar
PubMed
Search for other papers by Anna-Karin Elf in
Google Scholar
PubMed
Search for other papers by Viktor Johanson in
Google Scholar
PubMed
Search for other papers by Erik Elias in
Google Scholar
PubMed
Search for other papers by Erik Kristiansson in
Google Scholar
PubMed
Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Eva Forssell-Aronsson in
Google Scholar
PubMed
Search for other papers by Ola Nilsson in
Google Scholar
PubMed
replicates and was performed once due to the limited cell numbers. Cell plates were analysed 72 h after the start of the experiment. Tumour xenograft model and animal handling GOT1 tissue was transplanted subcutaneously to BALB/c nude mice (Janvier